Search

everythinglearnresearchcommunity

for

Search:↓

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

Topical calcitriol appears safe and may reduce hair loss during chemotherapy.

Chemotherapy in the first trimester of pregnancy is risky, but in the second and third trimesters, it's generally safe with careful drug selection and timing.

The document concluded that there were no effective ways to prevent hair loss from chemotherapy but treatments were being explored.

Some early breast cancer patients have long-term hair loss after chemotherapy, especially older and postmenopausal women.

Scalp cooling effectively prevents hair loss in breast cancer patients undergoing chemotherapy.

Recognizing and managing skin side effects from chemotherapy improves patient quality of life and treatment success.

Hair loss can be caused by cancer, treatments, or skin conditions, and trichoscopy helps diagnose it.

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

Scalp cooling is the only FDA-approved method to prevent hair loss from chemotherapy, but other treatments like minoxidil and PRP are being tested.

Some side effects of breast cancer chemotherapy last longer than others, and patient feedback can help improve care.

Melatonin may protect hair follicle stem cells from damage caused by chemotherapy.

Certain cancer drugs are strongly linked to nerve damage, requiring close monitoring and early treatment.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

Docetaxel is effective against various cancers but mainly causes neutropenia.

The new nanoparticles could improve melanoma treatment by working better than current options.

Docetaxel slightly extends prostate cancer survival but has significant side effects and high cost.

The drug combination was safe and showed promise in treating advanced tumors.

Hirsutism can occur in women with PCOS even if their androgen levels are normal, making diagnosis challenging.

Proper diet, monitoring, and protein supplements are crucial after bariatric surgery to prevent severe malnutrition.

The new chemotherapy combination for advanced lung cancer showed a 35.7% response rate but caused significant side effects.

Further testing of paclitaxel poliglumex for this cancer treatment is not justified.

Linagliptin slows down premature aging in certain mice.

Dental pulp stem cells are better for tissue repair, while fat tissue stem cells may be more suited for wound healing and hair growth.

Adding chemotherapy to tamoxifen improves survival for older breast cancer patients with positive nodes.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

A six-drug treatment for metastatic breast cancer showed promising results with low side effects, especially in premenopausal women.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.